These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400 [TBL] [Abstract][Full Text] [Related]
23. LPS binding protein and CD14 in the LPS dependent activation of cells. Tobias PS; Gegner J; Han J; Kirkland T; Kravchenko V; Leturcq D; Lee JD; Moriarty A; Mathison JC; Pugin J Prog Clin Biol Res; 1994; 388():31-9. PubMed ID: 7530370 [No Abstract] [Full Text] [Related]
24. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073 [TBL] [Abstract][Full Text] [Related]
25. [Binding relationships of fatty acids in lipid A of lipopolysaccharides from Pasteurella multocida]. Erler W; Feist H; Flossmann KD Arch Exp Veterinarmed; 1977; 31(2):203-9. PubMed ID: 901126 [TBL] [Abstract][Full Text] [Related]
27. NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site. Yang Y; Boze H; Chemardin P; Padilla A; Moulin G; Tassanakajon A; Pugnière M; Roquet F; Destoumieux-Garzón D; Gueguen Y; Bachère E; Aumelas A Biopolymers; 2009 Mar; 91(3):207-20. PubMed ID: 19107926 [TBL] [Abstract][Full Text] [Related]
28. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030 [TBL] [Abstract][Full Text] [Related]
29. Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities. Satoh M; Iwahori T; Sugawara N; Yamazaki M J Endotoxin Res; 2006; 12(1):21-38. PubMed ID: 16420741 [TBL] [Abstract][Full Text] [Related]
30. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883 [TBL] [Abstract][Full Text] [Related]
31. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14. Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028 [TBL] [Abstract][Full Text] [Related]
32. Identification of two novel LPS-binding proteins in Kupffer cells: implications in TNF-alpha production. Thomas P; Lazure DA; Moussa R; Bajenova O; Burke PA; Ganguly A; Forse RA J Endotoxin Res; 2006; 12(6):352-7. PubMed ID: 17254389 [TBL] [Abstract][Full Text] [Related]
33. The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides. David SA; Awasthi SK; Balaram P J Endotoxin Res; 2000; 6(3):249-56. PubMed ID: 11052180 [TBL] [Abstract][Full Text] [Related]
34. LPS, TLR4 and infectious disease diversity. Miller SI; Ernst RK; Bader MW Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698 [TBL] [Abstract][Full Text] [Related]
35. Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Roth RI; Kaca W; Levin J Prog Clin Biol Res; 1994; 388():161-72. PubMed ID: 7831356 [TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide binding protein from normal human plasma purified with high efficiency. Nanbo A; Nishimura H; Nagasawa S Protein Expr Purif; 1997 Jun; 10(1):55-60. PubMed ID: 9179291 [TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Su GL Am J Physiol Gastrointest Liver Physiol; 2002 Aug; 283(2):G256-65. PubMed ID: 12121871 [TBL] [Abstract][Full Text] [Related]
38. Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23. Appelmelk BJ; Qing AY; Helmerhorst EJ; Maaskant JJ; Abraham PR; Thijs LG; MacLaren DM Prog Clin Biol Res; 1995; 392():453-63. PubMed ID: 8524952 [TBL] [Abstract][Full Text] [Related]